Task shifting interventions for cardiovascular risk reduction in low-income and middle-income countries: A systematic review of randomised controlled trials

Gbenga Ogedegbe, Joyce Gyamfi, Jacob Plange-Rhule, Alisa Surkis, Diana Margot Rosenthal, Collins Airhihenbuwa, Juliet Iwelunmor, Richard Cooper

Research output: Contribution to journalArticle

Abstract

Objective: To evaluate evidence from published randomised controlled trials (RCTs) for the use of taskshifting strategies for cardiovascular disease (CVD) risk reduction in low-income and middle-income countries (LMICs). Design: Systematic review of RCTs that utilised a task-shifting strategy in the management of CVD in LMICs. Data Sources: We searched the following databases for relevant RCTs: PubMed from the 1940s, EMBASE from 1974, Global Health from 1910, Ovid Health Star from 1966, Web of Knowledge from 1900, Scopus from 1823, CINAHL from 1937 and RCTs from ClinicalTrials.gov. Eligibility criteria for selecting studies: We focused on RCTs published in English, but without publication year. We included RCTs in which the intervention used task shifting (non-physician healthcare workers involved in prescribing of medications, treatment and/or medical testing) and nonphysician healthcare providers in the management of CV risk factors and diseases (hypertension, diabetes, hyperlipidaemia, stroke, coronary artery disease or heart failure), as well as RCTs that were conducted in LMICs. We excluded studies that are not RCTs. Results: Of the 2771 articles identified, only three met the predefined criteria. All three trials were conducted in practice-based settings among patients with hypertension (2 studies) and diabetes (1 study), with one study also incorporating home visits. The duration of the studies ranged from 3 to 12 months, and the task-shifting strategies included provision of medication prescriptions by nurses, community health workers and pharmacists and telephone follow-up posthospital discharge. Both hypertension studies reported a significant mean blood pressure reduction (2/1 mm Hg and 30/15 mm Hg), and the diabetes trial reported a reduction in the glycated haemoglobin levels of 1.87%. Conclusions: There is a dearth of evidence on the implementation of task-shifting strategies to reduce the burden of CVD in LMICs. Effective task-shifting interventions targeted at reducing the global CVD epidemic in LMICs are urgently needed.

Original languageEnglish (US)
Article numbere005983
JournalBMJ open
Volume4
Issue number10
DOIs
StatePublished - 2014

    Fingerprint

ASJC Scopus subject areas

  • Medicine(all)

Cite this